EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Cobalamin Deficiency in Children and Adolescents with Sickle Cell Disease

Dunia Hatabah iD, Rachel Krieger, Lou Ann Brown iD, Frank Harris iD, Rawan Korman, Loretta Reyes iD, Jasmine Umana, Laura Benedit, Bridget A Wynn, Chris A Rees, Carlton Dampier iD, Claudia R Morris iD

Nutrients · 2025

DOI: 10.3390/nu17030597 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Nutrients, 2025. Verfasst von Dunia Hatabah und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pediatrics, Emory University School of Medicine, Atlanta, GA 30322, USA. Hauptthemen laut MEDLINE: Anemia, Sickle Cell, Vitamin B 12 Deficiency. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 60 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NHLBI NIH HHS, National Institutes of Health/National Center for Complementary and Integrative Health, Emory University Department of Pediatrics, Children's Healthcare of Atlanta, and the Pediatric Residency Investigative Scholars at Emory (PRISE) program.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background/Objective: Cobalamin (B12) deficiency is reported in 18% of adults with sickle cell disease (SCD) and only 10% without SCD; limited data are available on children. Diagnosing B12 deficiency is challenging given the lack of an established gold standard method of assessment and the unique renal features of SCD. B12 metabolism can be impacted by the clinical use of nitrous oxide gas (N2O), which is a standard therapy for SCD pain in some European countries. In response to emerging reports of neurologic sequalae in patients with SCD receiving N2O, we evaluated the prevalence of B12 deficiency in children with SCD pain.

Methods

Secondary analysis of prospective blood and urine samples in children aged 3–21 hospitalized with SCD pain. B12 deficiency was defined as plasma methylmalonic acid (MMA) > 592 nmol/L or urine MMA/creatinine ≥ 2.2 mmol/mol.

Results

Ninety-four children (13 ± 4 years, 54% female, 68% hemoglobin-SS, and 72% on hydroxyurea) were assessed. Further, 53% (50/94) had B12 deficiency diagnosed by either urine, plasma, or both; 27% (25/94) were deficient based on urine; 39% (37/94) were deficient by plasma; and 13% (12/94) were deficient by both plasma and urine. Plasma MMA and urine MMA/creatinine did not correlate with hemoglobin or mean corpuscular volume.

Conclusions

B12 deficiency was common in children with SCD. The absence of a gold standard for diagnosing B12 deficiency compounded with the reliability issues of testing modalities make it impractical to determine whether this is an over- or under-estimation of the true prevalence. Future studies to better understand the dynamics of B12 metabolism during acute and steady states in SCD are warranted and could elucidate the influence of acute SCD pain on these biomarkers.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Anemia, Sickle CellVitamin B 12 DeficiencyHumansChildFemaleMaleAdolescentChild, PreschoolMethylmalonic AcidVitamin B 12Prospective StudiesYoung AdultPrevalenceNitrous OxidePainBiomarkers

Stichwörter der Autor:innen

B12cobalaminnitrous oxidesickle cell disease

Substanzen

Methylmalonic AcidVitamin B 12Nitrous OxideBiomarkers

Autor:innen und Institutionen

  • Department of Pediatrics, Emory University School of Medicine, Atlanta, GA 30322, USA.
  • Children's Healthcare of Atlanta, Atlanta, GA 30329, USA.
  • Children's Hospital of Philadelphia, Philadelphia, PA 19104, USA.

ORCID-Profile: Dunia Hatabah, Lou Ann Brown, Frank Harris, Loretta Reyes, Carlton Dampier, Claudia R Morris

Förderung

  • NHLBI NIH HHS
  • National Institutes of Health/National Center for Complementary and Integrative Health
  • Emory University Department of Pediatrics, Children's Healthcare of Atlanta, and the Pediatric Residency Investigative Scholars at Emory (PRISE) program
  • NIH HHS
  • National Institutes of Health/National Heart Lung and Blood Institute
  • NCCIH NIH HHS
  • FDA
  • NIH/NHLBI

Zitieren

APA

Hatabah, D., Krieger, R., Brown, L. A., Harris, F., Korman, R., Reyes, L., Umana, J., Benedit, L., Wynn, B. A., Rees, C. A., Dampier, C., & Morris, C. R. (2025). Cobalamin Deficiency in Children and Adolescents with Sickle Cell Disease. Nutrients. https://doi.org/10.3390/nu17030597

Vancouver

Hatabah D, Krieger R, Brown LA, Harris F, Korman R, Reyes L, et al. Cobalamin Deficiency in Children and Adolescents with Sickle Cell Disease. Nutrients. 2025. doi:10.3390/nu17030597

BibTeX
@article{Hatabah2025,
  author = {Hatabah, Dunia and Krieger, Rachel and Brown, Lou Ann and Harris, Frank and Korman, Rawan and Reyes, Loretta and Umana, Jasmine and Benedit, Laura and Wynn, Bridget A and Rees, Chris A and Dampier, Carlton and Morris, Claudia R},
  title = {Cobalamin Deficiency in Children and Adolescents with Sickle Cell Disease},
  journal = {Nutrients},
  year = {2025},
  doi = {10.3390/nu17030597}
}
Kostenlos starten →